 |
| The natural
solution for good health, a clear complexion, more
energy and a long life. East Park Research's
patented olive leaf extract products are natural, and
our skin care products contain no Benzoyl Peroxide. |
|
|
|
|
|
| |
|
URGENT
BENZOYL PEROXIDE WARNING!* |
| |
|
Benzoyl
peroxide generates free radicals in the
skin. Its effect is similar to
unprotected sun exposure. The
redness of the skin (erythema), caused
by sun exposure and benzoyl peroxide, is
the result of free radicals (oxidative
stress) upon the skin. Repeated
sun exposure or benzoyl peroxide use
generates free radicals that damage the
skin's structure and cellular DNA,
resulting in premature aging of the
skin. The extent of the damage and
aging from benzoyl peroxide is
determined by the concentration of
benzoyl peroxide, the frequency of
application, and the duration of its
use. |
| |
|
Because
benzoyl peroxide generates free
radicals, it interferes with and slows
the healing process. The red and
brown marks that are a part of the acne
healing process may last weeks longer
when benzoyl peroxide is a regular part
of the daily regimen. |
| |
|
Benzoyl
peroxide has been linked to cancer for a
number of years and many research
journal entries state "benzoyl peroxide
is a free radical-generating skin tumor
promoting agent." Performing a
word search of the words "benzoyl
peroxide cancer" in PubMed in the
National Library of Medicine produces
102 articles from medical publications
dealing with research aspects of benzoyl
peroxide and cancer. About
two-thirds of the research supports
linkage between benzoyl peroxide and
skin cancer. |
| |
|
"In 1995
the FDA changed benzoyl peroxide from a
Category I (safe) to a Category III
(safety is uncertain) ingredient and
stated this action (56 FR 37622) was
based on new information that raised a
safety concern regarding benzoyl
peroxide as a tumor promoter in mice
..." Additionally the FDA charged
manufacturers with the responsibility of
providing this information to consumers
so they could make educated decisions.
A more complete FDA statement is at the
bottom of this page, for your reference. |
| |
|
FDA /
BENZOYL PEROXIDE ACTION: FEBRUARY
17, 1995* |
|
|
| |
|
Food
and Drug Administration (FDA) /
Department of Health and Human Services |
| |
|
"Topical Drug Products Containing
Benzoyl Peroxide: Required
Labeling" |
| |
|
"The Food
and Drug Administration (FDA) is
proposing additional labeling (warning
and directions) for all
topically-applied acne treatment drug
products containing benzoyl peroxide.
The warning advises consumers to avoid
unnecessary sun exposure and to use a
sunscreen when using a benzoyl peroxide
product to treat acne ..." |
| |
|
"The agency classified benzoyl peroxide
from its previous status Category I to
Category III status. This action
(56 FR 37622) was based on new
information that raised a safety concern
regarding benzoyl peroxide as a tumor
promoter in mice and a study that
reported that benzoyl peroxide has tumor
initiation potential." |
| |
|
"FDA evaluated these data and
information and determined that the
studies show that benzoyl peroxide is a
skin tumor promoter in more than one
strain of mice as well as in hamsters.
To date, topical studies (which have
shown only tumor promotion) have been of
short duration (about 52 weeks). |
| |
|
Although animal data and human
epidemiology data are available, the
agency has determined that further
studies are necessary to adequately
assess the tumorigenic potential of
benzoyl peroxide. These studies
are currently being conducted. |
| |
|
The agency acknowledges that it may take
several years for these studies to be
completed and analyzed, and for the
final determination to be made on
benzoyl peroxide's safety." |
|
|
*J Biomed Mater Res A. 2004 Dec
15;71(4):682-92 — J Biochem Mol Toxicol.
2004;18(2):107-14 —
Indian J Exp Biol. 2003
Aug;41(8):827-31 |
|
| |
|
|
